Literature DB >> 17851265

Intrafamilial clinical heterogeneity associated with a novel mutation of the retinal degeneration slow/peripherin gene.

Francesca Simonelli1, Francesco Testa, Valeria Marini, Emanuela Interlandi, Settimio Rossi, Derri Roman Pognuz, Gianni Virgili, Cecilia Garrè, Francesco Bandello.   

Abstract

AIMS: To identify the phenotypic variations in 6 related individuals affected by a novel mutation in the retinal degeneration slow/peripherin gene.
METHODS: Ten family members underwent ophthalmologic assessment with slit-lamp biomicroscopy, dilated fundus examination, fundus photography, autofluorescence imaging and electrophysiological tests. Genomic DNA was extracted from blood samples of all family members (n = 15) using the standard salting-out procedure.
RESULTS: The novel C165R mutation was identified in 8 individuals. Of these 8 patients, only 6 gave consent to the clinical study. They had a retinal disease characterized by an adulthood onset of symptoms, and their best corrected visual acuity was between 20/50 and 20/20. Fundus examination showed that 3 patients had typical fundus flavimaculatus: 1 had butterfly-shaped pattern dystrophy and 2 had incipient retinal changes.
CONCLUSION: We identified a novel mutation of the retinal degeneration slow/peripherin gene in a family affected by different patterns of retinal dystrophy. This is the first report of an association of fundus flavimaculatus with butterfly-shaped pattern dystrophy. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851265     DOI: 10.1159/000108118

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  3 in total

1.  ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.

Authors:  Daniel Strayve; Mustafa S Makia; Mashal Kakakhel; Haarthi Sakthivel; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

2.  PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease.

Authors:  Manon H C A Peeters; Mubeen Khan; Anoek A M B Rooijakkers; Timo Mulders; Lonneke Haer-Wigman; Camiel J F Boon; Caroline C W Klaver; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Anneke I den Hollander; Claire-Marie Dhaenens; Rob W J Collin
Journal:  Hum Mutat       Date:  2021-09-20       Impact factor: 4.700

3.  The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation.

Authors:  Wenjing Wu; Yusuke Takahashi; Henry Younghwa Shin; Xiang Ma; Gennadiy Moiseyev; Jian-Xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.